Resistance to nanoparticle albumin-bound paclitaxel is mediated by ABCB1 in urothelial cancer cells

Nanoparticle albumin-bound (nab)-paclitaxel appears to exhibit better response rates in patients with metastatic urothelial cancer of the bladder whom are pretreated with nab-paclitaxel compared with conventional paclitaxel. Paclitaxel may induce multidrug resistance in patients with cancer, while t...

Descripción completa

Detalles Bibliográficos
Autores principales: Vallo, Stefan, Köpp, Raoul, Michaelis, Martin, Rothweiler, Florian, Bartsch, Georg, Brandt, Maximilian P., Gust, Kilian M., Wezel, Felix, Blaheta, Roman A., Haferkamp, Axel, Cinatl, Jindrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453046/
https://www.ncbi.nlm.nih.gov/pubmed/28599410
http://dx.doi.org/10.3892/ol.2017.5986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453046/
https://www.ncbi.nlm.nih.gov/pubmed/28599410
http://dx.doi.org/10.3892/ol.2017.5986

Ejemplares similares